BTSG vs CHE
BTSG: An integrated, national home-based care provider delivering complementary pharmacy and clinical services to medically complex patients to reduce hospitalizations and lower costs. CHE: A diversified holding company operating a leading Medicare-reimbursed hospice and palliative care provider alongside a national residential and commercial plumbing services franchise.
Side-by-side fundamentals
| Metric | BTSG | CHE | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $69.74 | $503.52 | |
| Market cap as of 2026-07-23 | $13.7B | $6.7B | |
| P/E as of 2026-07-23 | 44.17 | 25.91 | CHE lower |
| PEG as of 2026-07-23 | 1.97 | 2.02 | BTSG lower |
| Net margin as of 2026-07-23 | +2.3% | +10.2% | CHE higher |
| Gross margin as of 2026-07-23 | +12.2% | +32.4% | CHE higher |
| Operating margin as of 2026-07-23 | +2.7% | +12.9% | CHE higher |
| ROE as of 2026-07-23 | +16.7% | +25.3% | CHE higher |
| ROA as of 2026-07-23 | +5.0% | +16.2% | CHE higher |
| Debt / equity as of 2026-07-23 | 1.27 | 0.12 | CHE lower |
| Revenue growth (YoY) as of 2026-07-23 | +18.0% | +2.1% | BTSG higher |
| Revenue CAGR (3y) SEC XBRL | +18.7% | +5.8% | BTSG higher |
| Dividend yield as of 2026-07-23 | n/a | +0.5% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 1.84 | 0.52 | |
| 1-year return as of 2026-07-22 close | +246.1% | +11.2% | BTSG higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.